Ramana Vaka

Assistant Lecturer
Office: 970-C, Medical Sciences Building
Phone (O): 780-492-1142
ramanavaka@ualberta.ca
Education:
PhD - Experimental Therapeutics and Pharmacology, University of Mississippi Medical Center, 2019
Postdoctoral Training: University of Southern California (AbbVie/Allergan), University of Ottawa Heart Institute, and University of Alberta
Teaching:
PMCOL 200: Drugs- An Introduction to Pharmacology
PMCOL 343: Scientific Basis of Pharmacology: Part I
PMCOL 344: Scientific Basis of Pharmacology: Part II
PMCOL 337: Experimental Procedures in Pharmacology
PMCOL 403: Advanced Topics in Pharmacology
PMCOL 450: Diabetes and Its Pharmacotherapy
PMCOL 425: Problem Solving in Pharmacology and Therapeutics
Research Interests: Heart failure, Hypertension, Mitochondria, Extracellular Vesicles, Preeclampsia
Dr. Ramana Vaka is an Assistant Lecturer in the Department of Pharmacology at the University of Alberta. He earned his PhD in Experimental Therapeutics and Pharmacology from the University of Mississippi Medical Center under the supervision of Dr. Babbette LaMarca. He subsequently completed postdoctoral training in clinical pharmacology at the University of Southern California/Allergan (AbbVie), Los Angeles/Irvine, California followed by translational cardiovascular research postdoctoral training at the University of Ottawa Heart Institute and the University of Alberta, Canada. His pre- and postdoctoral research has been supported by the American Heart Association and the University of Ottawa Heart Institute Foundation. Before joining the University of Alberta, he held an instructor role in Pharmacology at the University of Mississippi Medical Center. Dr. Vaka’s research interests span preeclampsia, maternal cardiovascular health, heart failure, cardiac metabolism, and extracellular vesicles. His current research program focuses on understanding the mechanisms underlying maternal cardiac dysfunction in preeclampsia and its contribution to long-term cardiovascular disease in women with a history of preeclampsia.
Publications:
Vaka, R., Amaral, L. M., Chambers, C. L., Campbell, N., Zheng, B., Roman, R. J., & LaMarca, B. (2026). Placental small-RNA sequencing reveals a distinct microRNA signature and its functional relevance in a preeclampsia rat model. Hypertension in Pregnancy, 45(1). https://doi.org/10.1080/10641955.2026.2726195
Vaka, R., Hinton, E., Edwards, K., & LaMarca, B. (2026). Placental mitochondrial impairment in preeclampsia patients. Hypertension in Pregnancy, 45(1). https://doi.org/10.1080/10641955.2026.2734436
Abuetabh Y, Schmidt MA, Naganuma M, Vaka R, El-Ghiaty MA, Braun S, Kwan EA, Zolondek MC, Sahid D, Khan L, Shandal RK, Trudeau AL, Li Y, Malik SO, Sun Q, Roth DK, Morales-Llamas DY, Levasseur JL, Ferdaoussi M, Fahlman RP, Dyck JR. Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone esters. JCI Insight. 2026 Jun 9;11(15):e201810.
doi: 10.1172/jci.insight.201810.